MichaelWilliamGaynonMD
Ophthalmology • Palo Alto, CARetinal Disease
Retinal Specialist at Stanford University School of Medicine
Dr. Gaynon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000Fax+1 650-725-6619
Summary
- Dr. Michael Gaynon is an ophthalmologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care and Lucile Salter Packard Children's Hospital Stanford. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 45 years. He specializes in retinal disease and is experienced in diabetic retinopathy, retinopathy of prematurity, macular degeneration, retinal detachment, and drug delivery systems.
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 1977 - 1978
Louisiana State University School of Medicine (New Orleans)Residency, Ophthalmology, 1973 - 1976
California Pacific Medical CenterInternship, Internal Medicine, 1972 - 1973
University of North Carolina at Chapel Hill School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1976 - 2026
NC State Medical License 1972 - 1992
LA State Medical License 1973 - 1986
AL State Medical License 1975 - 1975- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- AOA
- Honor Award American Academy of Ophthalmology
- Fellow (FAAO) American Academy of Ophthalmology
- Join now to see all
Clinical Trials
- To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions Start of enrollment: 2006 Oct 01
- Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions Start of enrollment: 2007 Feb 01
Publications & Presentations
PubMed
- 72 citationsThe Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years.William V. Good, William V. Good, R J Hardy, Velma Dobson, Earl A. Palmer
The British Journal of Ophthalmology. 2006-11-01 - 23 citationsEffects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.Dale L. Phelps, Kristi L. Watterberg, Tracy L. Nolen, Carol A. Cole, C. Michael Cotten
JAMA. 2018-10-23 - 5 citationsComplete visual recovery after incipient crao due to ocular hypoperfusion in a patient with moyamoya disease.Eleonora M. Lad, Shivanand P. Lad, Cindy Ung, Atul Jain, Gary K. Steinberg
Retinal Cases & Brief Reports. 2013-01-01
Professional Memberships
- Fellow
- Association for Research in Vision and OphthalmologyMember
- Retina SocietyMember
- American Society of Retinal SpecialistsMember
- Association of Pediatric Retinal SurgeonsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
